Marksans, whose product portfolio includes therapeutic segments of cardiovascular, central nervous system, antidiabetic, pain management, gastroenterology and anti-allergy drugs and whose market capitalisation stood at Rs 5,299.75 crore in August last …
New Delhi: Wearable devices such as smartwatches and smart rings that claim to measure blood glucose levels in real-time without piercing the skin may seem convenient for people with diabetes. …
New Delhi: The US Food and Drug Administration (FDA) has approved Omalizumab, which is sold under the brand name Xolair, to treat severe food allergies — making it the first …
New Delhi: The US Food and Drug Administration (USFDA) last week approved two breakthrough gene therapies — Casgevy by Vertex Pharmaceuticals and CRISPR Therapeutics, and Lyfgenia by Bluebird Bio — for sickle …
New Delhi: French biotech company Valneva, whose vaccine against mosquito-borne illness chikungunya received approval from the US Food and Drug Administration (USFDA) last week — becoming the first licensed vaccine …
Bengaluru: The deadly sickle cell disease (SCD), which causes blood cells to deform into a sickle shape, could potentially have two cures by the end of the year. A new …
MUMBAI: A US congressional panel has expressed concerns about the lack of effective action taken by the national drug regulator Food and Drug Administration (FDA) regarding quality lapses in manufacturing …